
Authorized markets enable price discovery, transfer, settlement, and institutional participation in economic interests tied to the Direct-to-Cell Capacity Asset.
Market participants evaluate certified performance, capacity demand, and MNO partnerships, device reach, regulatory rights, scarcity, and constellation scale.
Whole or fractional economic interests may be transferred subject to contractual, platform, and regulatory controls.
Ownership, entitlements, transfers, and settlement remain auditable throughout the secondary-market lifecycle.